Cargando…

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT

Detalles Bibliográficos
Autores principales: Decaux, O., Hulin, C., Perrot, A., Macro, M., Frenzel, L., Diels, J., Perualila, N. J., Ghilotti, F., Haefliger, B., Goldsztajn, E., Vernet, S., Thevenon, J., Willaime, M., Texier, N., Schecter, J. M., Madduri, D., Jackson, C., Valluri, S., Moreau, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429390/
http://dx.doi.org/10.1097/01.HS9.0000846488.02230.86
_version_ 1784779427652042752
author Decaux, O.
Hulin, C.
Perrot, A.
Macro, M.
Frenzel, L.
Diels, J.
Perualila, N. J.
Ghilotti, F.
Haefliger, B.
Goldsztajn, E.
Vernet, S.
Thevenon, J.
Willaime, M.
Texier, N.
Schecter, J. M.
Madduri, D.
Jackson, C.
Valluri, S.
Moreau, P.
author_facet Decaux, O.
Hulin, C.
Perrot, A.
Macro, M.
Frenzel, L.
Diels, J.
Perualila, N. J.
Ghilotti, F.
Haefliger, B.
Goldsztajn, E.
Vernet, S.
Thevenon, J.
Willaime, M.
Texier, N.
Schecter, J. M.
Madduri, D.
Jackson, C.
Valluri, S.
Moreau, P.
author_sort Decaux, O.
collection PubMed
description
format Online
Article
Text
id pubmed-9429390
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94293902022-08-31 P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT Decaux, O. Hulin, C. Perrot, A. Macro, M. Frenzel, L. Diels, J. Perualila, N. J. Ghilotti, F. Haefliger, B. Goldsztajn, E. Vernet, S. Thevenon, J. Willaime, M. Texier, N. Schecter, J. M. Madduri, D. Jackson, C. Valluri, S. Moreau, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429390/ http://dx.doi.org/10.1097/01.HS9.0000846488.02230.86 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Decaux, O.
Hulin, C.
Perrot, A.
Macro, M.
Frenzel, L.
Diels, J.
Perualila, N. J.
Ghilotti, F.
Haefliger, B.
Goldsztajn, E.
Vernet, S.
Thevenon, J.
Willaime, M.
Texier, N.
Schecter, J. M.
Madduri, D.
Jackson, C.
Valluri, S.
Moreau, P.
P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title_full P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title_fullStr P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title_full_unstemmed P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title_short P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT
title_sort p904: ciltacabtagene autoleucel vs treatments from real-world clinical practice for triple class exposed patients with multiple myeloma: adjusted comparisons based on cartitude-1 and the emmy french cohort
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429390/
http://dx.doi.org/10.1097/01.HS9.0000846488.02230.86
work_keys_str_mv AT decauxo p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT hulinc p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT perrota p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT macrom p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT frenzell p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT dielsj p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT perualilanj p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT ghilottif p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT haefligerb p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT goldsztajne p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT vernets p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT thevenonj p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT willaimem p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT texiern p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT schecterjm p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT maddurid p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT jacksonc p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT valluris p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort
AT moreaup p904ciltacabtageneautoleucelvstreatmentsfromrealworldclinicalpracticefortripleclassexposedpatientswithmultiplemyelomaadjustedcomparisonsbasedoncartitude1andtheemmyfrenchcohort